Shailaja Kasibhatla

9.1k citations

79 papers · 6.0k indexed · 1 hit paper · h-index 40

Co-authors: Douglas R. Green Ben Tseng John Drewe Thomas Brunner Laurent Genestier Sui Xiong Cai Artin Mahboubi Fernando Echeverri
Topics: Cell death mechanisms and regulation (21 papers)Synthesis and biological activity (14 papers)Synthesis and Characterization of Heterocyclic Compounds (10 papers)
Cited by: Organic Chemistry Toxicology Cancer Research
Journals: Proceedings of the National Academy of Sciences Journal of Biological Chemistry The Journal of Experimental Medicine
Partner nations: United States Switzerland Austria

In The Last Decade

Shailaja Kasibhatla

79 papers receiving 5.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

DNA Damaging Agents Induce Expression of Fas Ligand and Subsequent Apoptosis in T Lymphocytes via the Activation of NF-κB and AP-1

1998 627 citations Shailaja Kasibhatla, Thomas Brunner et al. Molecular Cell profile →

Peers

Countries citing papers authored by Shailaja Kasibhatla

Since Specialization

Citations

This map shows the geographic impact of Shailaja Kasibhatla's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shailaja Kasibhatla with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shailaja Kasibhatla more than expected).

Fields of papers citing papers by Shailaja Kasibhatla

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shailaja Kasibhatla. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shailaja Kasibhatla. The network helps show where Shailaja Kasibhatla may publish in the future.

Co-authorship network of co-authors of Shailaja Kasibhatla

This figure shows the co-authorship network connecting the top 25 collaborators of Shailaja Kasibhatla. A scholar is included among the top collaborators of Shailaja Kasibhatla based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shailaja Kasibhatla. Shailaja Kasibhatla is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	682P Preclinical and ongoing phase I study data of the CHK1 inhibitor BBI-355 in development for patients with oncogene amplification on extrachromosomal DNA (ecDNA) 2023 ·Annals of Oncology ·Alexander Drilon,(unknown),Alexander I. Spira,Monica Sharma,R. J. Hansen,(unknown),Shailaja Kasibhatla,Alok K. Tewari,(unknown),Kay‐Uwe Wagner,Timothy A. Yap	1
2	Quantitative Systems Pharmacology Modeling of Avadomide-Induced Neutropenia Enables Virtual Clinical Dose and Schedule Finding Studies 2021 ·The AAPS Journal ·R. Abbiati,Michael Pourdehnad,Soraya Carrancio,Daniel W. Pierce,Shailaja Kasibhatla,Mark McConnell,Matthew Trotter,Remco Loos,(unknown),Alexander V. Ratushny	3
3	Inhibition of Tumor Growth Progression by Antiandrogens and mTOR Inhibitor in a Pten -Deficient Mouse Model of Prostate Cancer 2009 ·Cancer Research ·Weisheng Zhang,Joe Jiang Zhu,Clay L. Efferson,Chris Ware,Jennifer Tammam,Minilik Angagaw,Jason Laskey,(unknown),Shailaja Kasibhatla,John F. Reilly,Cyrille Sur,Pradip K. Majumder	66
4	Discovery of 3-aryl-5-aryl-1,2,4-oxadiazoles as a new series of apoptosis inducers. 2. Identification of more aqueous soluble analogs as potential anticancer agents 2009 ·Bioorganic & Medicinal Chemistry Letters ·William Kemnitzer,Jared Kuemmerle,Han‐Zhong Zhang,Shailaja Kasibhatla,Ben Tseng,John Drewe,Sui Xiong Cai	39
5	Discovery of substituted 4-anilino-2-arylpyrimidines as a new series of apoptosis inducers using a cell- and caspase-based high throughput screening assay. 2. Structure–activity relationships of the 2-aryl group 2009 ·Bioorganic & Medicinal Chemistry Letters ·Nilantha Sirisoma,Azra Pervin,Bao Nguyen,Candace Crogan‐Grundy,Shailaja Kasibhatla,Ben Tseng,John Drewe,Sui Xiong Cai	13
6	Selective activation of apoptosis by a novel set of 4-aryl-3-(3-aryl-1-oxo-2-propenyl)-2(1H)-quinolinones through a Myc-dependent pathway 2008 ·Cancer Letters ·Gisela Claassen,(unknown),Candace Crogan‐Grundy,Mei Vaillancourt,(unknown),Sui Xiong Cai,John Drewe,Ben Tseng,Shailaja Kasibhatla	65
7	Synthesis of caged 2,3,3a,7a-tetrahydro-3,6-methanobenzofuran-7(6H)-ones: Evaluating the minimum structure for apoptosis induction by gambogic acid 2008 ·Bioorganic & Medicinal Chemistry ·Jared Kuemmerle,Songchun Jiang,Ben Tseng,Shailaja Kasibhatla,John Drewe,Sui Xiong Cai	23
8	MPC-6827: A Small-Molecule Inhibitor of Microtubule Formation That Is Not a Substrate for Multidrug Resistance Pumps 2007 ·Cancer Research ·Shailaja Kasibhatla,Vijay Baichwal,Sui Xiong Cai,Bruce L. Roth,Ira Skvortsova,Sergej Skvortsov,Peter Lukáš,Nicole M. English,Nilantha Sirisoma,John Drewe,Azra Pervin,Ben Tseng,Robert Carlson,Christopher M. Pleiman	110
9	4-Aryl-4H-chromenes as a new series of apoptosis inducers using a cell- and caspase-based high throughput screening assay, structure-activity relationships of the 7, 8-positions 2006 ·Cancer Research ·Sui Xiong Cai,William Kemnitzer,Shailaja Kasibhatla,Songchun Jiang,(unknown),Ben Tseng,John Drewe,Denis Labrecque,Serge Lamothe,Henriette Gourdeau	2
10	A Chemical Genetics Approach for the Discovery of Apoptosis Inducers:From Phenotypic Cell Based HTS Assay and Structure-Activity Relationship Studies, to Identification of Potential Anticancer Agents and Molecular Targets. 2006 ·Current Medicinal Chemistry ·Chenglong Xiong,John Drewe,Shailaja Kasibhatla	58
11	Discovery of substituted 4-anilino-2-(2-pyridyl)pyrimidines as a new series of apoptosis inducers using a cell- and caspase-based high throughput screening assay. Part 1: Structure–activity relationships of the 4-anilino group 2006 ·Bioorganic & Medicinal Chemistry ·Nilantha Sirisoma,Shailaja Kasibhatla,Bao Nguyen,Azra Pervin,Yang Wang,Gisela Claassen,Ben Tseng,John Drewe,Sui Xiong Cai	38
12	The discovery and mechanism of action of novel tumor-selective and apoptosis-inducing 3,5-diaryl-1,2,4-oxadiazole series using a chemical genetics approach 2005 ·Molecular Cancer Therapeutics ·Katayoun A. Jessen,Nicole M. English,(unknown),Sergei Maliartchouk,(unknown),Ling Qiu,(unknown),Jared Kuemmerle,Han‐Zhong Zhang,Kurt R. Gehlsen,John Drewe,Ben Tseng,Sui Xiong Cai,Shailaja Kasibhatla	67
13	Discovery and SAR of indole-2-carboxylic acid benzylidene-hydrazides as a new series of potent apoptosis inducers using a cell-based HTS assay 2004 ·Bioorganic & Medicinal Chemistry ·Han‐Zhong Zhang,John Drewe,Ben Tseng,Shailaja Kasibhatla,Sui Xiong Cai	88
14	Regulation of FasL by NF-κB and AP-1 in Fas-dependent Thymineless Death of Human Colon Carcinoma Cells 2000 ·Journal of Biological Chemistry ·Franklin G. Harwood,Shailaja Kasibhatla,István Peták,(unknown),Douglas R. Green,Janet A. Houghton	68
15	Expression of Fas Ligand in Activated T Cells Is Regulated by c-Myc 2000 ·Journal of Biological Chemistry ·Thomas Brunner,Shailaja Kasibhatla,Michael J. Pinkoski,(unknown),Nam Jin Yoo,Fernando Echeverri,Artin Mahboubi,Douglas R. Green	72
16	A ‘non-canonical’ DNA-binding element mediates the response of the Fas-ligand promoter to c-Myc 2000 ·Current Biology ·Shailaja Kasibhatla,Helen M. Beere,Thomas Brunner,Fernando Echeverri,Douglas R. Green	38
17	Regulation of Fas-Ligand Expression during Activation-induced Cell Death in T Lymphocytes via Nuclear Factor κB 1999 ·Journal of Biological Chemistry ·Shailaja Kasibhatla,Laurent Genestier,Douglas R. Green	224
18	The c-Jun N-Terminal Kinase Cascade Plays a Role in Stress-Induced Apoptosis in Jurkat Cells by Up-Regulating Fas Ligand Expression 1998 ·The Journal of Immunology ·Mary Faris,Niels Kokot,Kevin Latinis,Shailaja Kasibhatla,Douglas R. Green,Gary A. Koretzky,André E. Nel	218
19	DNA Damaging Agents Induce Expression of Fas Ligand and Subsequent Apoptosis in T Lymphocytes via the Activation of NF-κB and AP-1breakdown → 1998 ·Molecular Cell ·Shailaja Kasibhatla,Thomas Brunner,Laurent Genestier,Fernando Echeverri,Artin Mahboubi,Douglas R. Green	627
20	CD3- T cells with cis- or trans-acting mutations affecting expression of T cell receptor beta-chain mRNA 1992 ·The Journal of Immunology ·(unknown),Shailaja Kasibhatla,Eric A. Nalefski,A Rao	3

About Shailaja Kasibhatla

Shailaja Kasibhatla is a scholar working on Cancer Research, Toxicology and Organic Chemistry, having authored 79 papers that have together received 6.0k indexed citations. Recurring topics across this work include Cell death mechanisms and regulation (21 papers), Synthesis and biological activity (14 papers) and Synthesis and Characterization of Heterocyclic Compounds (10 papers). The work is most often cited by research in Organic Chemistry (2.4k citations), Toxicology (273 citations) and Cancer Research (864 citations). Shailaja Kasibhatla has collaborated with scholars based in United States, Switzerland and Austria. Frequent co-authors include Douglas R. Green, Ben Tseng, John Drewe, Thomas Brunner, Laurent Genestier, Sui Xiong Cai, Artin Mahboubi, Fernando Echeverri, Songchun Jiang and Candace Crogan‐Grundy. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Experimental Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact